Literature DB >> 9621027

A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

F Gao1, D L Robertson, C D Carruthers, S G Morrison, B Jian, Y Chen, F Barré-Sinoussi, M Girard, A Srinivasan, A G Abimiku, G M Shaw, P M Sharp, B H Hahn.   

Abstract

Non-subtype B viruses cause the vast majority of new human immunodeficiency virus type 1 (HIV-1) infections worldwide and are thus the major focus of international vaccine efforts. Although their geographic dissemination is carefully monitored, their immunogenic and biological properties remain largely unknown, in part because well-characterized virological reference reagents are lacking. In particular, full-length clones and sequences are rare, since subtype classification is frequently based on small PCR-derived viral fragments. There are only five proviral clones available for viruses other than subtype B, and these represent only 3 of the 10 proposed (group M) sequence subtypes. This lack of reference sequences also confounds the identification and analysis of mosaic (recombinant) genomes, which appear to be arising with increasing frequency in areas where multiple sequence subtypes cocirculate. To generate a more representative panel of non-subtype B reference reagents, we have cloned (by long PCR or lambda phage techniques) and sequenced 10 near-full-length HIV-1 genomes (lacking less than 80 bp of long terminal repeat sequences) from primary isolates collected at major epicenters of the global AIDS pandemic. Detailed phylogenetic analyses identified six that represented nonrecombinant members of HIV-1 subtypes A (92UG037.1), C (92BR025. 8), D (84ZR085.1 and 94UG114.1), F (93BR020.1), and H (90CF056.1), the last two comprising the first full-length examples of these subtypes. Four others were found to be complex mosaics of subtypes A and C (92RW009.6), A and G (92NG083.2 and 92NG003.1), and B and F (93BR029.4), again emphasizing the impact of intersubtype recombination on global HIV-1 diversification. Although a number of clones had frameshift mutations or translational stop codons in major open reading frames, all the genomes contained a complete set of genes and three had intact genomic organizations without inactivating mutations. Reconstruction of one of these (94UG114.1) yielded replication-competent virus that grew to high titers in normal donor peripheral blood mononuclear cell cultures. This panel of non-subtype B reference genomes should prove valuable for structure-function studies of genetically diverse viral gene products, the generation of subtype-specific immunological reagents, and the production of DNA- and protein-based subunit vaccines directed against a broader spectrum of viruses.

Entities:  

Mesh:

Year:  1998        PMID: 9621027      PMCID: PMC110237     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Complex mosaic structure of the partial envelope sequence from a Gambian HIV type 1 isolate.

Authors:  A Bobkov; R Cheingsong-Popov; M Salminen; F McCutchan; J Louwagie; K Ariyoshi; H Whittle; J Weber
Journal:  AIDS Res Hum Retroviruses       Date:  1996-01-20       Impact factor: 2.205

2.  HIV-1 subtype and second-receptor use.

Authors:  L Zhang; Y Huang; T He; Y Cao; D D Ho
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

3.  WWW-query: an on-line retrieval system for biological sequence banks.

Authors:  G Perrière; M Gouy
Journal:  Biochimie       Date:  1996       Impact factor: 4.079

4.  HIV-1 genetic diversity.

Authors:  F E McCutchan; M O Salminen; J K Carr; D S Burke
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

5.  Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.

Authors:  G Ferrari; W Humphrey; M J McElrath; J L Excler; A M Duliege; M L Clements; L C Corey; D P Bolognesi; K J Weinhold
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

6.  Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda.

Authors:  U Wieland; A Seelhoff; A Hofmann; J E Kühn; H J Eggers; P Mugyenyi; S Schwander
Journal:  J Gen Virol       Date:  1997-02       Impact factor: 3.891

7.  Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C.

Authors:  M O Salminen; B Johansson; A Sönnerborg; S Ayehunie; D Gotte; P Leinikki; D S Burke; F E McCutchan
Journal:  AIDS Res Hum Retroviruses       Date:  1996-09-20       Impact factor: 2.205

8.  Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization.

Authors:  M Cornelissen; G Kampinga; F Zorgdrager; J Goudsmit
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization.

Authors:  J Weber; E M Fenyö; S Beddows; P Kaleebu; A Björndal
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

10.  Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes.

Authors:  J Louwagie; F E McCutchan; M Peeters; T P Brennan; E Sanders-Buell; G A Eddy; G van der Groen; K Fransen; G M Gershy-Damet; R Deleys
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

View more
  95 in total

1.  Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance.

Authors:  A C Vicente; S M Agwale; K Otsuki; O M Njouku; D Jelpe; J A Idoko; E Caride; R M Brindeiro; A Tanuri
Journal:  Virus Genes       Date:  2001-03       Impact factor: 2.332

2.  Widespread intra-serotype recombination in natural populations of dengue virus.

Authors:  M Worobey; A Rambaut; E C Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

3.  Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana.

Authors:  V A Novitsky; M A Montano; M F McLane; B Renjifo; F Vannberg; B T Foley; T P Ndung'u; M Rahman; M J Makhema; R Marlink; M Essex
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Extensive homologous recombination among widely divergent TT viruses.

Authors:  M Worobey
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Authors:  Gillian M Hunt; Maria A Papathanasopoulos; Glenda E Gray; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

6.  Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies.

Authors:  M Gordon; T De Oliveira; K Bishop; H M Coovadia; L Madurai; S Engelbrecht; E Janse van Rensburg; A Mosam; A Smith; S Cassol
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Mosaic genomes of the six major primate lentivirus lineages revealed by phylogenetic analyses.

Authors:  Marco Salemi; Tulio De Oliveira; Valerie Courgnaud; Vincent Moulton; Barbara Holland; Sharon Cassol; William M Switzer; Anne-Mieke Vandamme
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Dynamics of HIV-1 recombination in its natural target cells.

Authors:  David N Levy; Grace M Aldrovandi; Olaf Kutsch; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

9.  Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.

Authors:  V Novitsky; H Cao; N Rybak; P Gilbert; M F McLane; S Gaolekwe; T Peter; I Thior; T Ndung'u; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Inhibition of human immunodeficiency virus type 1 isolates by the integrase inhibitor L-731,988, a diketo Acid.

Authors:  Ryan Reinke; Deborah J Lee; W Edward Robinson
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.